x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Ori Spotlight

Ori Spotlight covers the latest in cell and gene therapy. Jason C. Foster, Ori Biotech CEO will be talking to leaders from across the industry to find out more about how we can break down the barriers and seize the opportunities to make sure that every patient has access to life-changing treatments. Connect with Ori Biotech to learn more about partnering to pioneer innovative technologies in CGT manufacturing that bring CGT products to market at commercial scale at decreased costs while

science life sciences

All Episodes

00:54:16

Daniel Gibson: improving patient access to cell...

Ori Spotlight ·

2023/06/13

On this episode of the Ori Spotlight Podcast, we're joined by Daniel Gibson Director of Cell and Gene Therapy Services at Anthony Nolan. Anthony Nolan is a charity on a mission to improve the lives of people with blood cancer and blood disorders, by connecting patients and stem cell donors, funding research into cell therapies, and supporting patients along their transplant journey. Together, Jason and Daniel discuss the barriers limiting widespread patient access to cell therapies, why we

en

00:47:33

Dr Betty Woo: why it’s important to take calculated...

Ori Spotlight ·

2023/05/09

On this episode of the Ori Spotlight podcast, we're joined by Dr Elizabeth Woo, Vice President of Cell and Gene Therapy at ThermoFisher. With 20+ years of experience at ThermoFisher, Betty has contributed to the growth of the company's revenue from $4B to $40B through various technical, commercial and leadership roles. Throughout this episode, Betty provides her insights into how the cell and gene therapy sector is evolving and offers valuable advice for young professionals in the

en

00:50:22

John Lee: “Cellicon Valley” accelerates development...

Ori Spotlight ·

2023/04/18

On this episode of the Ori Spotlight podcast, we're joined by John Lee, Senior Vice President and Head of Cell Therapy at the Center for Breakthrough Medicines. With 20+ years of experience in cancer cell biology at Janssen and GSK, spanning small and large molecules and cell-based therapeutics, John unpicks some of the biggest challenges facing the cell and gene therapy industry. One hot topic within the industry is the “buy versus build” approach to manufacturing. As developers invest more

en

00:57:46

Amy Kappen: connecting CAR-T families with The Best...

Ori Spotlight ·

2023/03/28

We’re back with the Ori Spotlight Podcast, where we’ll be hosting conversations with experts and advocates from across the cell and gene therapy sector, and exploring the latest challenges and opportunities within the industry. In this episode, we talk to Amy Kappen, founder of the Best Day Ever Foundation. Amy founded the Foundation after her daughter Sophia passed away after battling with acute lymphoblastic leukemia (ALL) in 2017. For Amy and her family, CAR-T was “a modern day miracle” that

en

00:51:15

Philip Vanek – CTO, Gamma Biosciences

Ori Spotlight ·

2022/11/29

On episode 25 of the Ori Spotlight Podcast, Jason C. Foster is joined by Philip Vanek, CTO at Gamma Biosciences as they explore how the industry is evolving in a digitally connected world. Gamma Biosciences is a life sciences innovator focused on bioprocessing tools and technologies for the development and production of advanced therapies, including vaccines, biologics and cell and gene therapies. Philip is an entrepreneurial and strategic international business leader. Prior to Gamma Biosciences,

en

00:53:58

Matthew Durdy - CEO, CGT Catapult

Ori Spotlight ·

2022/11/08

In episode 24 of the Ori Spotlight Podcast, Jason C. Foster is joined by Matthew Durdy, CEO of CGT Catapult as they discuss the progression of the cell and gene therapy industry. CGT Catapult is an independent center of excellence that aims to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialization. CGT Catapult works with partners in academia and industry to ensure advanced therapies can be developed for use in

en

00:45:07

Jonathan Hay – Partner, Delin Ventures

Ori Spotlight ·

2022/10/25

In episode 23 of the Ori Spotlight Podcast, Jason C. Foster is joined by Jonathan Hay, Partner at Delin Ventures and Ori board member. Delin Ventures is a venture capital firm that invests in breakthrough technologies and life science businesses that can have a positive impact on human lives. Having supported Ori in their $100M Series B round, Jason joined Jonathan to discuss how Ori’s mission resonated with Jonathan as an investor, key challenges in the development and deployment of advanced

en

00:45:15

Elliot Menschik – Chief Digital Officer, Resilience

Ori Spotlight ·

2022/10/11

In episode 22 of the Ori Spotlight Podcast, Jason C. Foster is joined by Elliot Menschik Chief Digital Officer at Resilience, and Kevin Gordon Chief Digital Officer at Ori. Founded in 2020, Resilience is a manufacturing and technology company building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Elliot began his career as a physician and engineer before moving into the healthtech

en

00:36:25

The Whitehead and Jones Families, Patient Advocates

Ori Spotlight ·

2022/09/27

In episode 21, Ori CEO Jason C. Foster had the honour of being joined by two families, both of whom are strong advocates for increasing the accessibility of CAR-T therapy: Emily, Kari and Tom Whitehead from the Emily Whitehead Foundation, and Lucy and Lewis Jones, parents of Opie Jones. Aged 5, Emily Whitehead was diagnosed with acute lymphoblastic leukemia (ALL). After relapsing twice following conventional treatment, Emily was enrolled on a Phase I clinical trial for CAR-T therapy at the

en

01:08:30

Jason Bock – CEO, Cell Therapy Manufacturing Center...

Ori Spotlight ·

2022/09/14

In episode 20 of the Ori Spotlight Podcast, Jason C. Foster is joined by Jason Bock, CEO at CTMC (a joint venture between Resilience and MD Anderson Cancer Center) as they discuss bringing advanced therapies to patients at scale. Jason has also recently joined Ori as a member of our SAB - we’re honored to have Jason’s expertise and insights support us in achieving our mission. Jason Bock has substantial experience in biopharmaceutical development, where he has previously held senior positions at

en

00:45:46

Isabelle Rivière – Director of Cell Therapy and Cell...

Ori Spotlight ·

2022/08/31

For episode 19 of the Ori Spotlight Podcast, Jason C. Foster is joined by Isabelle Rivière, Director of Cell Therapy and Cell Engineering Laboratory at the Memorial Sloan-Kettering Cancer Center (MSKCC), one of the world’s leading cancer centers. Isabelle has also recently joined Ori as our newest SAB member – we’re honored to have her supporting us in achieving our mission. To this episode, Isabelle brings insights she has gathered from 25 years of experience within the cell and gene therapy

en

00:52:28

Stuart Milne - Chief Technology Officer, Ori Biotech

Ori Spotlight ·

2022/08/16

For episode 18 of the Ori Spotlight Podcast, Jason C. Foster is joined by Ori’s very own Chief Technology Officer, Stuart Milne. Stuart has extensive experience in the CGT sector, having held leadership positions across R&D, startups and scale-ups – including leading a multidisciplinary CGT R&D team from start-up (Asymptote, 2012) through to acquisition (GE Healthcare, 2017) and divestiture (Cytiva, 2020), and launching IOT-enabled products in CGT. Together, Jason and Stuart discuss how the

en

00:52:16

Mike Paglia - Chief Operating Officer, ElevateBio

Ori Spotlight ·

2022/07/12

For Episode 17 of the Ori Spotlight Podcast, Jason C. Foster is joined by Mike Paglia, COO of ElevateBio, a centralized R&D and manufacturing company developing its own innovative cell and gene therapies. Mike has 20 years of experience in biotechnology, working across the industry from therapeutic antibody manufacturing to drug development. Together, Jason and Mike discuss how ElevateBio supports the cell and gene therapy industry, the long-term benefits of digital manufacturing processes, and

en

00:49:37

Kevin Kyle and Carol Houts - Germfree

Ori Spotlight ·

2022/06/14

For episode 16 of the Ori Spotlight Podcast, Jason C. Foster is joined by Germfree CEO, Kevin Kyle and VP of Regulatory and Business Development, Carol Houts. Germfree specializes in the manufacture of mobile and modular cleanrooms, laboratory equipment, cGMP facilities and biosafety labs to deliver solutions across the life science spectrum. Together they sat down to explore how Germfree supported the industry through COVID-19 - adapting with innovation within decentralized manufacturing of cell

en

00:44:52

Jo Anne Valentino - Chief Operating Officer, Minaris...

Ori Spotlight ·

2022/04/19

For episode 15 of Ori Spotlight, Jason C. Foster is joined by Jo Anne Valentino, Chief Operating Officer at Minaris Regenerative Medicine as she shares her insights into cell and gene therapy development. Jo Anne has extensive experience in pharmaceutical manufacturing, having previously held senior positions at Merck and Novartis. Minaris Regenerative Medicine is a CDMO dedicated to the production of CGT products, offering high-quality clinical and commercial manufacturing services, developmental

en

00:45:28

John Connolly - Chief Scientific Officer, Parker...

Ori Spotlight ·

2022/03/16

In episode 14 of the Ori Spotlight Podcast, Jason C. Foster is joined by John Connolly, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy, who explained why and how the industry needs to increase the accessibility of CGT for patients. The Parker Institute is a research institute on a mission – to break down infrastructure barriers that have slowed progress in the development of immunotherapies. Their infrastructure builds collaboration between researchers, non-profits and

en

00:47:03

Mike Nicholson & Matt Haines - Inceptor Bio

Ori Spotlight ·

2022/02/23

In episode 13 of the Ori Spotlight Podcast Jason C. Foster sits down with Mike Nicholson (President and Chief Operating Officer) and Matt Haines (Vice President of Manufacturing Operations) at Inceptor Bio, as they share their insights into the cell and gene therapy space. Inceptor Bio is on a mission to cure difficult to treat cancers using next-generation cell therapy platforms. Their unique partnership model, with university oncology research programs, leverages their manufacturing resources and

en

00:50:22

Adam Wieschhaus and Shaan Gandhi - Directors,...

Ori Spotlight ·

2022/02/01

In Episode 12 of the Ori Spotlight Podcast, Jason C. Foster sits down with Northpond Ventures, investor in both Ori’s Series A and Series B funding. We caught up with Directors Adam Wieschhaus and Shaan Gandhi, as they share their insights into the cell and gene therapy space. Northpond Ventures is a $2.15 billion venture capitalist firm focused on life science, medicine, and technology; with 60 investments to date since its inception. Adam and Shaan lead their San Francisco and Boston offices

en

00:41:31

Paul Meister - Partner, Novalis LifeSciences

Ori Spotlight ·

2022/01/21

In episode 11 of the Ori Spotlight Podcast we sit down with Paul Meister, Partner at Novalis LifeSciences - lead investor of Ori Biotech’s series B round - as he shares his perspectives on the potential for CGT. Paul has extensive experience across the pharmaceutical, biotech and life science fields, having orchestrated the merger of Thermo Electron and Fisher Scientific before becoming chair of Thermo Fisher and, later, chair and CEO of Syneos Health. In this episode, he catches up with Jason C

en

00:45:44

Dr. Farlan Veraitch - Co-Founder and Chief Scientific...

Ori Spotlight ·

2021/11/16

In episode 10 of the Ori Spotlight Podcast we sit down with Farlan Veraitch, Co-Founder and Chief Scientific Officer at Ori Biotech. Farlan is an internationally recognized expert in CGT-manufacturing, with 15 years’ experience as a leading academic at University College London, pioneering innovative technologies in CGT bioprocessing. At Ori, he leads the research and development of Ori's revolutionary manufacturing technology platforms. In the podcast, Farlan joins Jason C. Foster to share his

en

49 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter